Skip to main content

Articles

Page 126 of 154

  1. The genetic background of rheumatoid arthritis (RA) is only partly understood, and several genes seem to be involved. The matrix metalloproteinases MMP1 (interstitial collagenase) and MMP3 (stromelysin 1) are tho...

    Authors: Sylvia Dörr, Nadine Lechtenböhmer, Rolf Rau, Gertraud Herborn, Ulf Wagner, Bertram Müller-Myhsok, Ingo Hansmann and Gernot Keyszer
    Citation: Arthritis Res Ther 2004 6:R199
  2. Authors: Martin Skoumal, Günther Haberhauer, Josef Feyertag, Eva Maria Kittl, Kurt Bauer and Attila Dunky
    Citation: Arthritis Res Ther 2004 6:73
  3. Endothelial cells are active participants in chronic inflammatory diseases. These cells undergo phenotypic changes that can be characterised as activated, angiogenic, apoptotic and leaky. In the present review...

    Authors: Jim Middleton, Laure Americh, Regis Gayon, Denis Julien, Luc Aguilar, Francois Amalric and Jean-Philippe Girard
    Citation: Arthritis Res Ther 2004 6:60
  4. T lymphocytes have been implicated in the pathogenesis of inflammatory arthritis for approximately 30 years. Over that period a vast literature has described the phenotype, location and behaviour of T cells de...

    Authors: Jeff Faint and Frances Hall
    Citation: Arthritis Res Ther 2004 6:55
  5. Chronic T cell responses, as they occur in rheumatoid arthritis, are complex and are likely to involve many mechanisms. There is a growing body of evidence that, in concert with the T cell antigen receptor sig...

    Authors: Monika C Brunner-Weinzierl, Holger Hoff and Gerd-R Burmester
    Citation: Arthritis Res Ther 2004 6:45
  6. To determine the contribution of IL-1β, tumor necrosis factor alpha (TNF-α) and IL-17 to AP-1, NF-κB and Egr-1 activation in rheumatoid arthritis, the effect of the cytokines used alone or in combination was m...

    Authors: Corinne Granet, Wova Maslinski and Pierre Miossec
    Citation: Arthritis Res Ther 2004 6:R190
  7. Authors: R Flierman, L Morgan, L van Duivenvoorde, RRP de Vries, WE Fibbe, TJW Huizinga, REM Toes and JM van Laar
    Citation: Arthritis Res Ther 2004 6(Suppl 1):95

    This article is part of a Supplement: Volume 6 Supplement 1

  8. Authors: PV Kasperkovitz, NL Verbeet, T Smeets, PP Tak, TWJ Huizinga, B Baltus, T Timmer, E Pieterman, M Fero, GS Firestein, AA Alizadeh, TCTM van der Pouw Kraan and CL Verweij
    Citation: Arthritis Res Ther 2004 6(Suppl 1):77

    This article is part of a Supplement: Volume 6 Supplement 1

  9. Authors: E Lubberts, MI Koenders, B Oppers-Walgreen, M Wagenmans, L van den Bersselaar, LAB Joosten, J Schurr, JK Kolls and WB van den Berg
    Citation: Arthritis Res Ther 2004 6(Suppl 1):55

    This article is part of a Supplement: Volume 6 Supplement 1

Annual Journal Metrics

  • 2022 Citation Impact
    4.9 - 2-year Impact Factor
    5.7 - 5-year Impact Factor
    1.501 - SNIP (Source Normalized Impact per Paper)
    1.592 - SJR (SCImago Journal Rank)

    2023 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    111 days submission to accept (Median)

    2023 Usage 
    3,331,819 downloads
    1,885 Altmetric mentions